Addiction Treatment
Addiction Treatment RSS Feed RSS

Medical Cannabis for Chronic Pain and Quality of Life

February 3, 2021
Pavan Madan, MD.
Pavan Madan, MD. Dr. Madan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Does marijuana use reduce pain and improve quality of life over time? This observational, uncontrolled trial suggests it might, but also identifies the need for more rigorous future studies.
Read More

Do We Need to Be Face-to-Face to Treat Alcohol Use Disorder?

February 3, 2021
Deepti Anbarasan, MD.
Deepti Anbarasan, MD. Dr. Anbarasan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
We are getting more comfortable with telemedicine-based platforms to provide care. But do they improve the quality of care for unhealthy alcohol use? This randomized, controlled trial compares in-person care with asynchronous, module-based care for people with alcohol use disorder.
Read More

Note From the Editor-in-Chief

December 10, 2020
Our patients—and we—are spending more time in front of screens, using apps, and reading content in the lay press about treatment options. “Should I use an app to help reduce substance use?” or “I read somewhere that this herb can help; what are your thoughts?” or “Have you read your...
Read More

Smartphone Apps as Adjuncts for Substance Use Treatment

December 10, 2020
Rehan Aziz, MD.
Rehan Aziz, MD. Associate Professor of Psychiatry and Neurology, Rutgers Robert Wood Johnson Medical School. Dr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Smartphone apps are a useful, patient-centered resource for continued substance use treatment. We’ll explore the two current FDA-cleared SUD treatment apps as well as other popular ones on the market to help you determine the best approach for discussing these apps with your patients.
Read More
EXPERT Q&A

Alternative Therapies for SUDs

December 10, 2020
Steven Novella, MD

Steven Novella, MD
Assistant Professor of Neurology, Yale School of Medicine. Dr. Novella has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Not all alternative therapies are created equal. In this interview with Dr. Steven Novella, we discuss the prevalence of alternative therapies among patients with substance use disorders (SUDs) as well as the state of evidence for (or against) commonly utilized forms of complementary and alternative treatments for SUDs.
Read More

When to Stop Addiction Treatment: How Long Is Enough?

December 10, 2020
Michael Weaver, MD, FASAM.
Michael Weaver, MD, FASAM. Professor and medical director at the Center for Neurobehavioral Research on Addictions, University of Texas Medical School. Dr. Weaver has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Addiction is often lifelong phenomenon, but many patients may still wish to end treatment. We discuss the reasons why a patient might ask to “complete” their treatment and provide you with strategies for talking with patients about ceasing therapeutic treatments for substance use disorders.
Read More
EXPERT Q&A

Opioid Use Disorders and Serious Mental Illness

December 10, 2020
Sandra Gomez-Luna, MD

Sandra Gomez-Luna, MD
Clinical Assistant Professor at Yale University. Adult, adolescent, and child psychiatrist in Darien, CT. Dr. Gomez-Luna has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Those with serious mental illness and unhealthy opioid use have special treatment considerations due to polypharmacy and overlapping stigma. Dr. Gomez-Luna walks us through these nuances and explains microdosing of buprenorphine—a helpful technique for starting treatment in patients who may have other opioids on board.
Read More

Can Assertive Treatment Improve Treatment Adherence in Young Adults With Opioid Use Disorder?

December 10, 2020
Deepti Anbarasan, MD.
Deepti Anbarasan, MD. Dr. Anbarasan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Adherence may often limit effectiveness of medications for opioid use disorder among youth. In this randomized controlled trial, young adults with opioid use disorder were randomized to either youth opioid recovery support (an assertive intervention designed to increase adherence) or treatment as usual, both involving extended-release naltrexone.
Read More
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
Featured Video
Featured Podcast
Recommended

About

Shop Online

Newsletters

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.